Basic Bright Eye
In the US, eye health is a major concern for those over 60 years of age. The eye is the most susceptible organ to oxidative damage caused by light, toxins (smoke), atmospheric oxygen and abrasion. As ultraviolet and blue light pass through the retina to the photoreceptors (rods and cones) and the pigmented epithelial (PE) cells, reactive oxygen species (free radicals) are generated. If there are insufficient antioxidants available to neutralize free radicals, the eye undergoes excessive oxidative damage. Dr. J’s Natural Basic Bright Eye helps combat these conditions. This supplement supports healthy eyesight and promotes optimal eye function & healthy retinol tissue. This formula provides excellent support for those who want to maintain eye health and also for those seeking macular support as they age.
- Provides key antioxidant support for eyes
- Supports macular health
- Protects macula against light damage
- Increases ocular circulation
Contains 60 capsules
INGREDIENTS:Zinc, Taurine, N-Acetyl-L-Cysteine, Alpha Lipoic Acid, Bilberry Fruit Extract, Quercetin Dihydrate, Ginkgo biloba, Lutein, Lycopene, Zeaxanthin
Other Ingredients: Natural Vegetable Capsules, Magnesium Cellulose, Stearic Acid, Silicon Dioxide
DIRECTIONS: Take 1 capsule per day or as recommended by your healthcare professional.*
PLEASE READ THE ENTIRE LABEL CAREFULLY PRIOR TO USE.
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Protocatechuic Acid (PCA) is an amazing new radical addition to the health and wellness industry. Backed by evidence-based science, PCA is the essential and effective tool all humans will need in order to keep harmful viruses from infecting their bodies and even threatening their overall health. PCA’s unique formula has not only proven effective in fighting harmful microbes, but it has also shown to be an excellent source for the following 5 health benefits:
- Antibiotic (broad-spectrum)
Head researcher and orthopedic surgeon, Dr. Lanny Johnson, has spent over 15 years dedicated to credible, evidence-based research on PCA. Following his search, 17 US patents were granted supporting the abundant antimicrobial and antiviral properties of PCA. This includes the US patent giving sole ownership of the PCA ingredient, requiring other companies to seek the approval of Dr. Johnson in order to use this unique, multi-patented reagent. PCA’s unique physical structure and medically-researched antiviral properties can provide a microbe shield, limiting the exposure to bacteria and viruses, including the virus causing COVID-19.
Two independent contract laboratories tested PCA as an antiviral reagent against SARS CoV2 (COVID-19):
THE ILLINOIS INSTITUTE OF TECHNOLOGY - CHICAGO, IL
The experiment aimed to replicate the transmission of the virus in the clinical environment against a sanitizer coating of skin, masks, hard objects, and ventilation filters. The PCA crystalline coating on an article of metal, plastic and/or cloth was believed to kill COVID-19 on contact. Results measured by Log difference converted to no less than 90-99% inactivation or "kill" at 10 and 60 minutes after contact.
MRI GLOBAL - KANSAS CITY, MO
The second study’s objective was to determine if the PCA’s crystal-coated surfaces have the ability to inhibit the growth of the SARS CoV2 (COVID-19). PCA coating on various articles resulted in the inactivation of the live COVID-19 virus. The earliest effective time of the PCA crystals was immediately and at 24 hours after the sprayed crystals had dried on the surface. In other words, the results were stronger at this laboratory study with a log difference conversion to a 99% plus inactivation or "kill" at 10, 60, and 120 minutes after contact.